Innate Pharma
(NASDAQ:IPHA)
$2.38
-0.08[-3.25%]
At close: Apr 18
$2.38
0[0.00%]
After Hours: 8:26AM EDT

Innate Pharma Stock (NASDAQ:IPHA), Earnings Estimates, EPS, and Revenue

Innate Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 21
EPS
$-0.100
Quarterly Revenue
$66.3M
Annual Revenue
(as of Dec 31)
$51.9M

Analyze the earnings history of Innate Pharma using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
03/21/2024AMIPHAFY-$0.75-$0.10$58.87M$66.35MGet Alert
09/14/2023AMIPHAH1$0.09$0.02$49.88M$43.48MGet Alert
03/23/2023AMIPHAFY-$0.65-$0.75$28.25M$58.87MGet Alert
09/15/2022AMIPHAH1-$0.36$0.09$18.91M$49.88MGet Alert
03/24/2022AMIPHAFY-$0.65$28.25MGet Alert
09/15/2021AMIPHAH1-$0.36$18.91MGet Alert

FAQ

Q

When is Innate Pharma (NASDAQ:IPHA) reporting earnings?

A

Innate Pharma (IPHA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 21, 2024 for FY.

Q

What were the latest earnings per share (EPS) for Innate Pharma (NASDAQ:IPHA)?

A

Innate Pharma (IPHA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 21, 2024 for FY and the Actual EPS was $-0.10, which missed the estimate of $0.00.

Q

What were Innate Pharma’s (NASDAQ:IPHA) revenues?

A

Innate Pharma (IPHA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 21, 2024 for FY and the Actual Revenue was $66.3M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch